Sergei Gryaznov
Patrimonio netto: 64 650 $ in data 31/05/2026
Patrimonio netto: 64 650 $ in data 31/05/2026
Sergei M.
Gryaznov is the founder of Lynx Therapeutics, Inc. (1993).
Current job includes Chief Scientific Officer at MAIA Biotechnology, Inc. (2019 - present).
Former jobs include Chemistry Director at Geron Corp.
(2013) and Chief Technology Officer at Exicure Operating Co. Education includes graduate and doctorate degrees from Moscow State University Lomonosov.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2026 | 46.511 ( 0,08% ) | 64 650 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2019 |
| Società | Posizione | Fine |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 01/01/2013 |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Corporate Officer/Principal | 01/01/1997 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Moscow State University Lomonosov
Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops cancer therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale